Prone Positioning Not Relevant to Survival Rate in Patients with ARDS
|
By HospiMedica International staff writers Posted on 30 Nov 2009 |
Prone positioning during mechanical ventilation may not improve survival duration in patients with acute respiratory distress syndrome (ARDS), according to a new study.
Researchers at the Ospedale Maggiore Policlinico di Milano (Italy) conducted the multicenter randomized Prone-Supine II trial to evaluate possible outcome benefits of prone positioning in patients with ARDS and moderate or severe hypoxemia. A total of 342 adults with ARDS receiving mechanical ventilation at 23 centers in Italy, and two in Spain, were enrolled in the study, and were prospectively stratified into subgroups with moderate and severe hypoxemia. The participants were randomly selected to supine positioning (174 patients) or prone positioning for 20 hours per day (168 patients) during ventilation. The main endpoint of the study was 28-day all-cause mortality, and secondary endpoints were 6-month mortality and mortality at intensive care unit discharge, organ dysfunction, and complication rate associated with prone positioning.
The researchers found that for the overall entire study population evaluated between February 2004 and June 2008, prone and supine positioning were associated with similar mortality rates at 28 days and six months; however, the prone group had a significantly higher complication rate. For patients with moderate hypoxemia, outcomes were also similar in the prone and supine groups at 28 days and at 6 months. For patients with severe hypoxemia, 28-day mortality rate was 37.8% in the prone group and 46.1% in the supine group, and six-month mortality rate was 52.7% and 63.2%, respectively. Positioning was not associated with any apparent differences in median sequential organ failure assessment (SOFA) scores, ventilator-free days, or intensive care unit length of stay. The study was published in the November 11, 2009, issue of the Journal of the American Medical Association (JAMA).
"Do the findings of this trial, together with those of previous studies, represent the end of the prone position technique?” inquired lead author Paolo Taccone, M.D., and colleagues of the department of anesthesia. "Undoubtedly, the data of the present trial together with previous results clearly indicate that prolonged prone positioning, in the unselected ARDS population, is not indicated as a treatment. However, its potential role in patients with the most severe hypoxemia, for whom the possible benefit could outweigh the risk of complications, must be further investigated.”
Related Links:
Ospedale Maggiore Policlinico di Milano
Researchers at the Ospedale Maggiore Policlinico di Milano (Italy) conducted the multicenter randomized Prone-Supine II trial to evaluate possible outcome benefits of prone positioning in patients with ARDS and moderate or severe hypoxemia. A total of 342 adults with ARDS receiving mechanical ventilation at 23 centers in Italy, and two in Spain, were enrolled in the study, and were prospectively stratified into subgroups with moderate and severe hypoxemia. The participants were randomly selected to supine positioning (174 patients) or prone positioning for 20 hours per day (168 patients) during ventilation. The main endpoint of the study was 28-day all-cause mortality, and secondary endpoints were 6-month mortality and mortality at intensive care unit discharge, organ dysfunction, and complication rate associated with prone positioning.
The researchers found that for the overall entire study population evaluated between February 2004 and June 2008, prone and supine positioning were associated with similar mortality rates at 28 days and six months; however, the prone group had a significantly higher complication rate. For patients with moderate hypoxemia, outcomes were also similar in the prone and supine groups at 28 days and at 6 months. For patients with severe hypoxemia, 28-day mortality rate was 37.8% in the prone group and 46.1% in the supine group, and six-month mortality rate was 52.7% and 63.2%, respectively. Positioning was not associated with any apparent differences in median sequential organ failure assessment (SOFA) scores, ventilator-free days, or intensive care unit length of stay. The study was published in the November 11, 2009, issue of the Journal of the American Medical Association (JAMA).
"Do the findings of this trial, together with those of previous studies, represent the end of the prone position technique?” inquired lead author Paolo Taccone, M.D., and colleagues of the department of anesthesia. "Undoubtedly, the data of the present trial together with previous results clearly indicate that prolonged prone positioning, in the unselected ARDS population, is not indicated as a treatment. However, its potential role in patients with the most severe hypoxemia, for whom the possible benefit could outweigh the risk of complications, must be further investigated.”
Related Links:
Ospedale Maggiore Policlinico di Milano
Latest Critical Care News
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
- AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreSurgical Techniques
view channel
Bioengineered Heart Patch Improves Cardiac Function in Advanced Heart Failure
Severe heart failure occurs when damaged heart muscle can no longer generate adequate cardiac output, leaving patients symptomatic and at high risk despite modern therapies. Advanced cases often progress... Read more
Fracture Plating System Combines Anatomical Fit with Streamlined Instrumentation
Fracture management involves diverse anatomies and injury patterns that can make plate fit and fixation strategy challenging. Surgeons need both intraoperative efficiency and flexibility, while hospitals... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







